New 12-Month Tofersen Data Presented by Dr. Miller at ENCALS Meeting

Dr. Miller recently presented updated data for the Phase 3 Tofersen trial at the ENCALS Meeting in Edinburgh, Scotland.

Slides from the presentation can be viewed here: https://investors.biogen.com/static-files/4e9393b8-0f67-47a3-a331-05ef3ac7fc63